Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction - Zhou, Youlian; Xu, Zhenjiang Zech; He, Yan; Yang, Yunsheng; Liu, Le; Lin, Qianyun; Nie, Yuqiang; Li, Mingsong; Zhi, Fachao; Liu, Side; Amir, Amnon; González, Antonio; et al. (mSystems, 2018)
Keywords: Biomarkers; Crohn's disease; Diagnosis; Disease; disease activity; Dysbacteriosis; Fecal microflora; Feces; Firmicutes; Gastroenterology; Geography; gut microbiota; Health care; Hospitals; Host-Microbe Biology; Immunotherapy; Inflammatory bowel disease; Inflammatory bowel diseases; Infliximab; infliximab treatment; Intestinal microflora; Intestine; Laboratories; Microbiomes; Microbiota; Minority & ethnic groups; Monoclonal antibodies; Multiculturalism & pluralism; Noninvasive evaluation; Pathogenesis; Research Article; Studies; TNF inhibitors; Tumor necrosis factor-TNF; Tumor necrosis factor-α; Ulcerative colitis; Beijing China; La Jolla California; California; United States--US; China; disease activity; infliximab treatment; gut microbiota; inflammatory bowel disease